Aldeyra Therapeutics, Inc. (ALDX) is a publicly traded Healthcare sector company. As of May 21, 2026, ALDX trades at $1.60 with a market cap of $96.51M and a P/E ratio of -2.76. ALDX moved +0.00% today. Year to date, ALDX is -63.44%; over the trailing twelve months it is -34.32%. Its 52-week range spans $1.07 to $7.20. Analyst consensus is buy with an average price target of $5.50. Rallies surfaces ALDX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Aldeyra Therapeutics, Inc. (ALDX) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. ALDX moved +0.00% today. Analyst consensus is buy.
| Metric | Value |
|---|---|
| Price | $1.60 |
| Market Cap | $96.51M |
| P/E Ratio | -2.76 |
| EPS | $-0.56 |
| Dividend Yield | 0.00% |
| 52-Week High | $7.20 |
| 52-Week Low | $1.07 |
| Volume | 1.22K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-33.85M |
| Gross Margin | 0.00% |
2 analysts cover ALDX: 0 strong buy, 1 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $5.50.